The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by reintroducing the manufacture and distribution of cellular products for use in human subjects participating in clinical trials under investigational new drug (IND) applications for the cell product.
está buscando activamente contratistas calificados para research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) con reserva para empresas WOSB. Esta designación de reserva significa que las empresas elegibles enfrentan menos competencia de empresas más grandes.
¿Buscas más oportunidades?
Explora nuestro directorio completo de contratos gubernamentales